Seasonal Affective Disorder (SAD), often called "winter depression," is a type of depression that follows a seasonal pattern. Typically, symptoms emerge during the fall and winter months when daylight hours decrease.
Nov 6, 2024Saxenda is intended to be used in conjunction with improved diet and exercise habits, rather than as a standalone treatment. The medication is administered as a daily injection under the skin and can be taken at any time, regardless of meal schedules. This approach to weight management is part of a broader effort to reduce the risks associated with obesity and related health issues.
Some people have shared that they conceived after years of infertility only after starting Ozempic. These unexpected pregnancies have led to the term "Ozempic babies." This raises the question: Could the use of Ozempic actually be linked to increased fertility or unexpected pregnancies?
Ozempic, Wegovy, Zepbound, or other GLP-1 drugs can achieve an average weight loss of 15% of their body weight. However, not everyone taking these drugs will undergo such weight loss. Some patients who take these medications may eventually reach a plateau, during which the body resists further weight loss despite continued efforts.
Could Ozempic lead to suicidal thoughts? While the risk of suicidal ideation isn't listed as a side effect of GLP-1 drugs like Ozempic and Wegovy, the FDA is taking a closer look.
The most effective approach to weight loss is a gradual one, aiming for a reduction of 1-2 pounds per week. This method ensures a sustainable, healthy journey rather than quick, drastic changes. Setting realistic goals and staying motivated are key to this process. Remember, weight loss is a marathon, not a sprint, and the benefits of managing obesity extend far beyond the numbers on a scale.
Prescription weight loss drugs are generally prescribed for individuals who have a significant level of obesity, typically measured by body mass index (BMI), and often for those who have obesity-related health conditions. Understanding the potential side effects and costs associated with these medications is also important for choosing the right medication.
On November 8, the U.S. Food and Drug Administration (FDA) announced the approval of a new weight management drug, Zepbound (tirzepatide), developed by Eli Lilly and Company. This approval is noteworthy because Zepbound is the first obesity treatment to work by targeting two specific hormone receptors.
Zepbound appears to have an edge for strictly obesity treatment due to its FDA approval for this use and its dual-action mechanism. However, Ozempic remains a valuable option, particularly for patients who also need diabetes management. Ultimately, the "better" drug depends on individual patient needs, medical history, and how they respond to the treatment.
Alli is a medication containing orlistat and the only FDA-approved over-the-counter medication for weight loss. This medication is intended for those who have previously attempted weight management through diet and exercise alone, and are now seeking pharmaceutical help.